Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VYVGART safely and effectively. See full prescribing information for VYVGART. VYVGART® (efgartigimod alfa-fcab) injection, for intravenous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
VYVGART is indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.
- generic_name
- efgartigimod alfa
- product_names
- EFGARTIGIMOD ALFA
- ndc
- 73475-3041, 73475-3041-5
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en